SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-019752
Filing Date
2023-06-01
Accepted
2023-06-01 08:36:15
Documents
15
Period of Report
2023-06-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41340
2 ex99-1.htm EX-99.1 16873
3 ex99-1_001.jpg GRAPHIC 5955
  Complete submission text file 0001493152-23-019752.txt   293889

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20230601.xsd EX-101.SCH 4003
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20230601_def.xml EX-101.DEF 27110
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20230601_lab.xml EX-101.LAB 37477
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20230601_pre.xml EX-101.PRE 25731
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5853
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 23983113
SIC: 2834 Pharmaceutical Preparations